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Abstract 
Background: Implantable loop recorders (ILR) have been found to be useful in the diagnosis 
and management of syncope of unclear etiology. The clinical symptoms of abnormalities seen 
during ILR monitoring have not been adequately studied. 
Aim: The aim of this retrospective study was to determine the clinical symptoms which were 
the best predictors of asystolic or bradycardic responses during ILR monitoring. 
Methods: Patients with either asystole or bradycardia recorded during ILR monitoring were 
analyzed from our database. The clinical characteristics of these patients were compared to 
the patients with ILR’s who did not have recorded bradycardic episodes. The episodes were 
characterized as being convulsive or nonconvulsive, brief (<5 minutes) or prolonged (> 5 
minutes), and having had a prodrome or no prodrome. 
Results: Eleven patients (4 males and 7 females; age 39 ±11years) had asystole or bradycardia 
on ILR monitoring. Eleven patients (2 males and 9 females; age 46±23) had no bradycardiac 
events. Palpitations, convulsive syncope, prolonged episode, and prodrome were present in 
37% vs. 74% (P = 0.125), 62% vs. 0% (P = 0.002), 87% vs. 0% (P=0), and 73% vs. 13% 
(P=0.009) patients, respectively, in the asystole/bradycardia and non-bradycardia groups. In 
the asystole/bradycardia group eight patients had bradycardia (HR < 20) for > 10 seconds 
and three patients had asystole >10 seconds. 
Conclusion: Convulsive syncope, prolonged loss of consciousness during syncopal episode, 
and absence of prodrome or aura are clinical predictors of asystole or bradycardia on ILR 
monitoring. 
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Introduction 
Ambulatory cardiac monitoring with Holter or 
external loop recorders is frequently employed in the 
evaluation of patients with recurrent syncope. How-
ever, several non-randomized studies demonstrate a 
relatively low (<40%) diagnostic yield from this ap-
proach [1-5]. Implantable loop recorders (ILR’s), by 
contrast, allow for a more prolonged period of moni-
toring as well as automatic activation during events, 
resulting in a higher diagnostic yield than traditional 
monitoring techniques [6-12]. During ILR monitoring 
of patients with recurrent syncope, bradycardic 
events are encountered more frequently than are 
tachycardiac ones [13-15]. The clinical symptoms most 
predictive of significant bradycardic events (such as 
prolonged sinus pauses or complete heart block) re-
corded during ILR monitoring have not been well Int. J. Med. Sci. 2009, 6 
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reported. The aim of the present study was to identify 
the clinical characteristics and symptoms obtained 
from patient histories that best correlate with signifi-
cant bradycardic events recorded during ILR moni-
toring. 
Methods 
The study was a retrospective analysis which 
was approved by the University of Toledo Institu-
tional Review Board. A comprehensive review of pa-
tient charts was performed to identify patients of un-
explained syncope who had received ILR and had 
asystolic (>10 second pause) or bradycardic (< 20 
beats per minute) response corresponding to syncopal 
event during ILR monitoring.  
Inclusion criterion 
We queried our data base of implanted loop re-
corders. We identified 150 patients who received ILR 
over a period of 8 years for evaluation of unexplained 
nature of their syncope. Out of these 150 patients only 
14 had either a bradycardic (n=11) or a tachycardiac 
response (n=3) recorded on ILR during episodes of 
syncope. Patients were included in the study if they 
had either syncope or symptoms during monitoring 
which resembled the index syncope episode that lead 
to evaluation. Patients included in the study had un-
dergone an extensive evaluation including head up 
tilt test, cardiac electrophysiology study and 24 hour 
holter monitor and 1 month event recorder prior to 
implantation of ILR. Another 8 patients who had re-
ceived loop implants during the same time frame and 
had no arrhythmia recorded during an episode of the 
syncope were also include to make groups compara-
ble. These patients were followed for a period of 9±3 
months after rhythm directed therapy for recurrence 
of any syncope. 
The information about the clinical symptoms 
was obtained from patient charts and physician let-
ters. The clinical symptoms which were obtained from 
these sources included 
1. Presence of Aura: Aura included subjective 
nature of symptoms like lightheadedness, dizziness 
feeling of passing out. It was considered present or 
absent if the patient had aura during the episode of 
syncope (while being on ILR monitoring) and resem-
bled the index episode. 
2. Duration of syncope: The duration of syncope 
was determined from the loss of consciousness to full 
recovery of consciousness. The duration also included 
the postictal confusion if it was a convulsive syncope. 
We defined episodes of loss of consciousness as pro-
longed if they were > 5 minutes. The estimate of du-
ration of loss of consciousness was obtained from the 
people witnessing the event 
3. Convulsive Syncope. Syncopal episodes were 
labeled as convulsive if the patients had convulsions 
during the episodes. These convulsions were myo-
clonic in nature and were witnessed by family mem-
bers or friends. None of our patients had loss of 
bladder or bowel controls during these episodes. 
4. Palpitations: Patient histories were reviewed 
for presence or absence of palpitation immediately 
prior to syncope. Due to the specific nature of palpi-
tations this symptom was not included in the aura. 
Statistics 
All statistical analyses were done using SPSS. 
The continuous data was presented as mean ±SD and 
categorical data as percentages. T-test for comparison 
of means and chi-square test for categorical data was 
used. Significance was achieved with P value < 0.05. 
Results 
Total of 22 patients of refractory syncope were 
included in this study. These patients had suffered 
from recurrent episodes of syncope (> 2 in 6 months). 
All of these patients had a negative work-up includ-
ing head up tilt test (HUTT), 24 hour holter, 30 day 
event monitor and cardiac electrophysiology studies. 
Some of these patients had undergone stress and 
coronary angiography as well as electroencephalo-
graphy and CT scan. All the evaluations turned out to 
be inconclusive. In view of negative initial inconclu-
sive work-up patients received implantable loop re-
corders. The average duration of monitoring with an 
ILR was 6 months. 
The baseline clinical characteristics of patients 
with asystolic or bradycardic responses during ILR 
monitoring (Group 1) are compared with those with-
out asystolic or bradycardic responses (Group 2) in 
Table 1. Eleven patients (4 males and 7 females; age 39 
±11) had asystole or bradycardia on ILR monitoring. 
Eight patients had bradycardia (HR < 20) for > 10 
seconds and 3 patients had asystole >10 seconds in 
group 1. 
Eleven patients in group 2 (2 males and 9 fe-
males; age 46±23) had either tachycardia (n=3) or a 
sinus rhythm (n-8) recorded during an episode syn-
cope. 
One patent with tachycardia in Group 2 had 
Ventricular Tachycardia (HR > 140) and episodes of 
atrial fibrillation (HR 180). Two patients had atrio-
ventricular re-entrant tachycardia with HR (200).   
These episodes of arrhythmias either tachycardia 
or bradycardia were associated either with syncope 
during ILR monitoring. Int. J. Med. Sci. 2009, 6 
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Table 1: Baseline clinical characteristics in two groups of 
patients 
Clinical Characteristics    Group1 (N=11)    Group 2 (N=11) P 
Age    39±11   46±23  NS 
Race (Caucasian)%   90   94  NS 
Male: Female   4:7   2:9  NS 
Symptoms      
Palpitations %   37   74  0.125 
Convulsive syncope %   62   0  0.002 
Episode > 5 min. %   87   0  0.001 
Prodrome %   13   73  0.009 
Group 1= Patients with asystolic or bradycardic response on ILR 
monitoring. 
Group 2= Patients without asystolic or bradycardic response on ILR 
monitoring. 
 
Symptoms (Table 1 and Figure 1) 
1. Aura or prodrome: Only thirteen percent of 
patients in group1 had aura or warning signs before 
syncope compared to 73% in group 2 (p=0.01). 
2. Duration: Eighty seven percent of patients in 
group 1 had prolonged episode compared to none in 
group 2 (p=0.0001). 
3. Palpitations: Thirty seven percent of patients 
in group 1 had palpitations compared to 74% in group 
2 (p=0.12). 
4. Convulsive Syncope. Convulsive syncope was 
seen in 62% of patients in group1 and none in group 2 
(p=0.002). 
Age, gender, and race were similar in the two 
groups. In this study, fourteen patients had positive 
testing on ILR monitoring. In group 1, eight patients 
had bradycardia (HR < 20) for > 10 seconds and three 
patients had asystole >10 seconds. One of the patients 
had a 44-second sinus pause on ILR monitoring (Fig 
2). Dual chamber pacemaker was placed in all eleven 
patients in group 1 in view of either asystole or com-
plete AV block recorded on ILR during a syncopal 
episode. Two patients in group 2 who were noted to 
have supraventricular tachycardia underwent ra-
diofrequency ablation therapy. The patient with ven-
tricular tachycardia and atrial fibrillation received an 
implantable cardioverter defibrillator as well as 
medical management for paroxysmal atrial fibrilla-
tion. Following rhythm directed therapy, none of 
these patients had any further episodes of syncope 
over 6±3 months.  
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Figure 1: Clinical presentation of patients in different groups. Int. J. Med. Sci. 2009, 6 
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Figure 2: Recording downloaded from loop recorder showing prolonged Ventricular asystole and profound AV block. (44 
second). 
 
Discussion 
Unexplained syncope can pose a unique diag-
nostic challenge for physicians especially when the 
initial workup such as HUTT, electrophysiology 
studies, 24 hour holter monitor or 30 day event re-
corder is inconclusive. Implantable loop recorders 
have been shown to improve diagnosis and, thus fa-
cilitate rhythm directed therapy in this subgroup of 
patients [3-16]. In our study of 22 patients, 14 had an 
arrhythmic etiology. Eleven patients had bradyar-
rhythmia on ILR monitoring.  
Our study is unique as the clinical symptoms of 
the syncope in patients with bradyarrhythmic re-
sponses (the most common arrhythmia that has been 
reported during prolonged monitoring with ILR) 
have not been studied to date. It is interesting that 
abrupt onset (lack of prodrome), convulsive activity, 
and prolonged episodes of loss of consciousness were 
significantly associated with bradycardic responses 
during ILR monitoring. Interestingly, some of the 
patients in our study were labeled as having psycho-
genic syncope for years before the ILR monitoring 
revealed the diagnosis. The result of the recurrent and 
unpredictable nature of these syncopal episodes can 
result in a marked reduction in the quality of life in 
many of these patients [17].  
Syncope can sometimes be confused with sei-
zures. Some studies have reported that 30-42% of pa-
tients who were initially diagnosed with epilepsy had 
syncope with convulsive activity due cardiovascular 
etiology [20, 21, 22]. The pathophysiology of syncope 
provoked convulsive activity is complex. Asystole 
and sinus pauses in our patients were long enough to 
result in severe hypotension and cerebral hypoxia, 
which in turn could have lead to convulsive activity. 
Engel et al [23] reported seizure-like activity following 
periods of cerebral hypoxia. It has also been reported 
that in episodes of syncope associated with convul-
sive activity, the duration of loss of consciousness 
tends to be longer, as is the time to full recovery. In 
our study, these episodes lasted more than 5 min from 
onset to full return of consciousness (including pos-
tictal confusion period). In addition, all our patients 
who had a bradycardic/asystolic response on ILR 
monitoring had abrupt onset of syncope with no pro-
drome or aura, which predisposed them to suffer 
trauma from an episode. Sud et al [24] in their recent Int. J. Med. Sci. 2009, 6 
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report of predicting cause of syncope from clinical 
histories found that syncope occurring without aura 
or prodrome is associated with spontaneous ar-
rhythmic etiology predominantly bradycardia.  
Given a small number of patients in our study 
population and retrospective nature of the study an 
adequately powered prospective study is needed to 
validate these results, nevertheless the results of our 
study are consistent with those of other studies 
[13-15,23,24]. 
In our study, ILR monitoring by guiding rhythm 
directed therapy in all patients who tested positive 
helped prevent further syncope. None of the patients 
has yet had recurrence of their syncope following 
definitive treatment.  
Limitation 
This study was retrospective in nature and fol-
lowed a small number of patients. The information 
about the clinical symptoms was obtained from pa-
tient charts and physician letters. There was no ques-
tionnaire used to assess the symptoms. Another limi-
tation of the study was a recall bias on the part of 
family members or friends witnessing these episodes. 
The study included only patients with unexplained 
syncope and thus the results can not be generalized.  
Conclusion 
In the group of patients with recurrent unex-
plained syncope, severe bradycardia/asystole was the 
most common positive finding recorded during ILR 
monitoring. The clinical symptoms that were found to 
have the consistent association with severe bradycar-
dia and asystole include lack of prodrome, convulsive 
activity and prolonged loss of consciousness.  
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